These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 31737616)

  • 21. LPA signaling is required for dopaminergic neuron development and is reduced through low expression of the LPA1 receptor in a 6-OHDA lesion model of Parkinson's disease.
    Yang XY; Zhao EY; Zhuang WX; Sun FX; Han HL; Han HR; Lin ZJ; Pan ZF; Qu MH; Zeng XW; Ding Y
    Neurol Sci; 2015 Nov; 36(11):2027-33. PubMed ID: 26169757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson's disease.
    Oiwa Y; Yoshimura R; Nakai K; Itakura T
    Brain Res; 2002 Aug; 947(2):271-83. PubMed ID: 12176170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glutathione
    Jewett M; Dickson E; Brolin K; Negrini M; Jimenez-Ferrer I; Swanberg M
    Front Neurol; 2018; 9():222. PubMed ID: 29681884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
    Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
    J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neural metabolite changes in corpus striatum after rat multipotent mesenchymal stem cells transplanted in hemiparkinsonian rats by magnetic resonance spectroscopy.
    Fu W; Zheng Z; Zhuang W; Chen D; Wang X; Sun X; Wang X
    Int J Neurosci; 2013 Dec; 123(12):883-91. PubMed ID: 23768098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Naringin treatment induces neuroprotective effects in a mouse model of Parkinson's disease in vivo, but not enough to restore the lesioned dopaminergic system.
    Kim HD; Jeong KH; Jung UJ; Kim SR
    J Nutr Biochem; 2016 Feb; 28():140-6. PubMed ID: 26878791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor.
    Choi-Lundberg DL; Lin Q; Schallert T; Crippens D; Davidson BL; Chang YN; Chiang YL; Qian J; Bardwaj L; Bohn MC
    Exp Neurol; 1998 Dec; 154(2):261-75. PubMed ID: 9878166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopaminergic differentiation of neural progenitors derived from placental mesenchymal stem cells in the brains of Parkinson's disease model rats and alleviation of asymmetric rotational behavior.
    Park S; Kim E; Koh SE; Maeng S; Lee WD; Lim J; Shim I; Lee YJ
    Brain Res; 2012 Jul; 1466():158-66. PubMed ID: 22634376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exercise-Induced Neuroprotection and Recovery of Motor Function in Animal Models of Parkinson's Disease.
    Palasz E; Niewiadomski W; Gasiorowska A; Wysocka A; Stepniewska A; Niewiadomska G
    Front Neurol; 2019; 10():1143. PubMed ID: 31736859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of bone marrow mesenchymal stem cell secretome by ECM-like hydrogels.
    Silva NA; Moreira J; Ribeiro-Samy S; Gomes ED; Tam RY; Shoichet MS; Reis RL; Sousa N; Salgado AJ
    Biochimie; 2013 Dec; 95(12):2314-9. PubMed ID: 23994751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protective action of recombinant neurturin on dopaminergic neurons in substantia nigra in a rhesus monkey model of Parkinson's disease.
    Li H; He Z; Su T; Ma Y; Lu S; Dai C; Sun M
    Neurol Res; 2003 Apr; 25(3):263-7. PubMed ID: 12739234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell secretome based approaches in Parkinson's disease regenerative medicine.
    Marques CR; Marote A; Mendes-Pinheiro B; Teixeira FG; Salgado AJ
    Expert Opin Biol Ther; 2018 Dec; 18(12):1235-1245. PubMed ID: 30422014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Alternation of proteins in brain of Parkinson's disease model rats after the transplantation of TH-NTN gene modified bone marrow mesenchymal stem cells].
    Huang Y; Chang C; Zhang JW; Gao XQ
    Zhonghua Yi Xue Za Zhi; 2012 Sep; 92(33):2353-6. PubMed ID: 23158567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can mesenchymal stem cells reduce vulnerability of dopaminergic neurons in the substantia nigra to oxidative insult in individuals at risk to Parkinson's disease?
    Datta I; Bhonde R
    Cell Biol Int; 2012 Jul; 36(7):617-24. PubMed ID: 22417707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Periprostatic implantation of human bone marrow-derived mesenchymal stem cells potentiates recovery of erectile function by intracavernosal injection in a rat model of cavernous nerve injury.
    You D; Jang MJ; Lee J; Jeong IG; Kim HS; Moon KH; Suh N; Kim CS
    Urology; 2013 Jan; 81(1):104-10. PubMed ID: 23122545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Puerarin promoted proliferation and differentiation of dopamine-producing cells in Parkinson's animal models.
    Shiying L; Xinhui Q; Guanghua J; Feng N; Feng L; Shumei C; Fan H
    Biomed Pharmacother; 2018 Oct; 106():1236-1242. PubMed ID: 30119192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polylysine-modified polyethylenimine (PEI-PLL) mediated VEGF gene delivery protects dopaminergic neurons in cell culture and in rat models of Parkinson's Disease (PD).
    Sheikh MA; Malik YS; Xing Z; Guo Z; Tian H; Zhu X; Chen X
    Acta Biomater; 2017 May; 54():58-68. PubMed ID: 28025049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Effect of Human Umbilical Cord Mesenchymal Stromal Cells in Protection of Dopaminergic Neurons from Apoptosis by Reducing Oxidative Stress in the Early Stage of a 6-OHDA-Induced Parkinson's Disease Model.
    Chi H; Guan Y; Li F; Chen Z
    Cell Transplant; 2019 Dec; 28(1_suppl):87S-99S. PubMed ID: 31775521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dextran-coated iron oxide nanoparticle-improved therapeutic effects of human mesenchymal stem cells in a mouse model of Parkinson's disease.
    Chung TH; Hsu SC; Wu SH; Hsiao JK; Lin CP; Yao M; Huang DM
    Nanoscale; 2018 Feb; 10(6):2998-3007. PubMed ID: 29372743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physical exercise and human adipose-derived mesenchymal stem cells ameliorate motor disturbances in a male rat model of Parkinson's disease.
    Cucarián JD; Berrío JP; Rodrigues C; Zancan M; Wink MR; de Oliveira A
    J Neurosci Res; 2019 Sep; 97(9):1095-1109. PubMed ID: 31119788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.